Medical Genetics Flashcards
Describe the molecular genetic basis and clinical aspects of Huntington’s Disease
Onset typically between 30-50 years
Characterised by progressive chorea (involuntary movements), dementia and psychiatric symptoms
Autosomal Dominant with Genetic Anticipation
Unstable length mutation in the HTT gene
Number of CAG repeats increased from 10-35 to 36-120
This repeat encodes a polyglutamine tract
Expansion of tract causes insoluble protein aggregates and neurotoxicity
State the genetic conditions tested for (and the tests used) during pregnancy
Down Syndrome: Combined Ultrasound (Nuchal Translucency Increases in DS) and Biochemical Screening (CUBS)
Describe the role of BRCA1/2 mutations in the contribution to cancer
BRCA1/2 proteins are large nuclear proteins and with roles including DNA repair, transcriptional regulation of other genes and cell-cycle regulation
They promote double-stranded DNA repair by homologous recombination
Briefly describe Sanger DNA Sequencing
i.e. Fluorescent Dideoxynucleotide Sequencing
Used in detection of point mutations
Analyses a single gene at a time
Describe X-Linked Dominant Inheritance
e.g. Vitamin D Resistant Rickets
No male to male transmission
Vertical pattern of inheritance
Male-Female Transmission = All Daughters Affected
Female-Female Transmission = 50% of Daughters Affected
F:M = 2:1
Describe the basis of next generation DNA sequencing
i.e. Massively Parallel Sequencing
Of many or all genes
Used to find small mutations somewhere in the exome
Describe the difference between Tumour Suppressor Genes, Proto-Oncogenes and Oncogenes
TSG: Normally inhibit progression through cell cycle and cell prilferation, promote apoptosis or act as stability genes
Mutation Results in Loss of Function
Requires 2 Mutated Copies to Become Tumourigenic
Proto-Oncogenes: Normally stimulate cell cycle or promote cell division/growth
Activation by mutation results in Oncogenes with Gain of Function in protein
Only needs one mutated copy for tumourigenic effect
Describe the features of autosomal dominant inheritance
e.g. Achondroplasia
Affects every generation
Males and Females equally affected
Vertical pattern of inheritance
50% chance of child being affected if a parent is heterozygous
Disease = Aa or AA, Healthy = aa
Define ‘Cascade Screening’
Systematic identification and testing of members of the family of a proband with a particular disease of interest
(aka testing the family of a patient diagnosed with a disease such as CF)
State the genetic conditions tested for (and the test method) during the neonatal period
Heel Spot on Guthrie Card
Phenylketonuria and Medium-Chain Acyl-CoA Dehydrogenase Deficiency (Mass Spectrometry)
Congenital Hypothyroidism and Cystic Fibrosis (Immuno-Assay)
Sickle Cell Disorder (High-Performance Liquid Chromatography)
Describe the clinical aspects and molecular genetic basis of Duchenne Muscular Dystrophy
Onset at 3yrs, Wheelchair by 12yrs
X-Linked Recessive Inheritance
Serum Creatine Kinase leaks from damaged muscle fibres into serum
Out-Of-Frame Deletion Mutations
Describe the concept of ‘modifier genes’
Genetic variants that can affect the manifestation of a disease by altering indirectly influencing expression of another gene
This may help explain the variable expressivity seen in some mutations, and may affect the age of onset, rate of disease progression and severity of symptoms
Describe the clinical aspects and molecular genetic basis of Cystic Fibrosis
Characterised by recurrent lung infections and exocrine pancreatic insufficiency
CFTR mutation results in defective chloride ion channels and increased thickness of secretions
Most common mutation is F508del (in-frame deletion of one codon resulting in loss of phenylalanine ‘F’ at position 508 )
Prevents normal protein folding and insertion into the plasma membrane
Briefly describe the main autosomal trisomies
Down’s: Trisomy 21, Learning Difficulties, Heart Defects, Hypothyroidism
Edwards’s: Trisomy 18, Small Chin, Clenched Hands, Malformation of Organs, Profound Learning Difficulties if Survive Past 1 Year
Patau: Trisomy 13, Congenital Heart Disease, 50% SR at 1/12, 10% at 1Yr, Profound Learning Difficulties
Describe the concept of ‘variable expression’ in Mendelian Inheritance
Variable Expression: Two people in the same family, who have inherited the same mutation in the same gene, may have different disease severities or age of onset